[Hiring] Director - US Field HEOR Scientist @Bristol Myers Squibb

Role Description

The Field HEOR Scientist works within a field matrix team to engage Access organizations and decision-makers within their assigned accounts. They combine the technical knowledge of HEOR with the knowledge of the U.S. healthcare system’s business models to effectively engage, deliver, and generate impactful data to support medication access decision-making.

• The Field HEOR Scientist is a field-based position focusing on servicing large national GPO, Network Aggregator, and Pathway customers.
• Conduct health economics and outcomes research as part of a cross-functional matrix team in an internal-facing role.
• Lead clinical engagement with key access customers in a field-facing role.
• Collaborate on the development and implementation of the US HEOR strategy, plans, and research.
• Work closely with home office medical teams to develop, interpret, and disseminate data/information assessing the medical value of BMS assets.
• Direct research strategy to ensure BMS answers key questions in the healthcare marketplace driven by direct payer insights.
• Lead Health Economics and Outcomes Research for any given therapeutic area.
• Concentrate field-facing activities on specific accounts, including regional managed care accounts and key integrated delivery networks.
• Develop sustainable customer relationships and discuss comprehensive scientific, health economic, epidemiology, and quality of life information.
• Work closely with the Heme/Onc National Account Executives, MSLs, and home office medical matrix teams.
• Attend medical congresses and key regional meetings to collect and provide meaningful insights.
• Assist Sr. Director in mentoring junior fHEOR personnel.
• Be seen as the SME by access matrix colleagues.
• Link science/data to business needs of customers and provide solutions compliantly.
• Work with the leadership team to lead specific projects/initiatives that impact the broader field HEOR team, Home Office HEOR team, or cross-functional matrix teams.

Qualifications

• Advanced Graduate degree required: PhD, PharmD, MS, or MPH with an emphasis in health services research, health economics research, public health, health services, or related field.
• A Masters level degree will be considered if specific to health economics or outcomes research, with appropriate clinical background and years of experience.
• Minimum ten years of previous work experience in the oncology sector or pharmaceutical industries with a primary focus on Market Access.
• Experience in Solid Tumors, Hematology, and cell therapy preferred.
• Proven ability to demonstrate proficiency in using scientific resources to effectively present information to TL/HCPs.
• Demonstrated expertise in health economics and outcomes research; candidate should include their publication list.
• Demonstrate a high level of business acumen, leadership & customer focus.
• Proven ability to translate insights into scientific opportunities for research & shape BMS strategy.
• Must possess the ability to understand, interpret and make recommendations concerning the evolving US healthcare marketplace.
• Must have a proven ability to build customer relationships.
• Demonstrated strong problem-solving and communications skills.
• Flexibility to travel is required.
• Ability to drive a company-provided car is essential.
• Must meet the requirements of “Qualified Driver” as determined by the Company.

Benefits

• Eligibility to participate in comprehensive benefit plans, including wellbeing support, retirement and financial protection benefits, and insurance offerings.
• U.S.-based exempt employees are eligible for Flexible Time Off (FTO) and 11 paid company holidays each year.
• Non-exempt employees receive 160 hours of paid vacation annually for new hires, 11 paid company holidays, and 3 optional holidays.
• Access to additional time-off benefits, including paid sick leave, up to two paid volunteer days per year, and leaves of absence for various needs.
• Eligible employees enjoy an annual Global Shutdown between Christmas Day and New Year's Day.